 People with CF may be listed in a disease registry that allows researchers and doctors to track health results and identify candidates for clinical trials.Women who are pregnant or couples planning a pregnancy can have themselves tested for the "CFTR" gene mutations to determine the risk that their child will be born with CF.Testing is typically performed first on one or both parents and, if the risk of CF is high, testing on the fetus is performed.